Search
for

    Sort by

    Research 241–270 of 1000+

    1. Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action Annals of Clinical Pathology · 2026
    2. THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS International Journal of Innovative Technologies in Social Science · 2026
    3. Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model Journal of Assisted Reproduction and Genetics · 2026
    4. CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME International Journal of Innovative Technologies in Social Science · 2026
    5. Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show Psychiatric News · 2024
    6. Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art ̒Ulūm-i dārūyī · 2023
    7. Impact of Thyroid Dysfunction on Hair Disorders Cureus · 2023
    8. 571 Human Hair Follicles can “Taste”: Stimulation of the Bitter Taste Receptor TAS2R4 Inhibits Hair Growth Ex Vivo by Up-Regulating TGF-β2 Journal of Investigative Dermatology · 2022
    9. REAL WORLD STUDY ON ORAL ESTRADIOL TREATMENT IN TRANSGENDER WOMEN Journal of the ASEAN Federation of Endocrine Societies · 2022
    10. Pharmacological Control of Reproduction in the Dog and Cat 2019
    11. A(1-7) reduces pathologies associated with SLE in MRL-<i>lpr</i> mice The Journal of Immunology · 2018
    12. 1333 Spheroids cell cultures as a promising study model for hair follice regeneration Journal of Investigative Dermatology · 2018
    13. Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach DOAJ (DOAJ: Directory of Open Access Journals) · 2017
    14. Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome Gynecology Obstetrics and Reproductive Medicine · 2016
    15. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    16. Actualités du SOPK Annales D Endocrinologie · 2006
    17. LPA3, a unique G protein-coupled receptor for lysophosphatidic acid Progress in lipid research · 2010 · 31 citations
    18. TRPV3 Ion Channel: From Gene to Pharmacology International Journal of Molecular Sciences · 2023 · 2 citations
    19. 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations Journal of the American Academy of Dermatology · 2026
    20. Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration Aging · 2026
    21. A Novel Cosmetic Formulation That Rapidly Reduces Hair Shedding in Females Journal of Cosmetic Dermatology · 2024
    22. Molecular studies of transient receptor potential Vanilloid 3 (TRPV3) OPAL (Open@LaTrobe) (La Trobe University) · 2024
    23. Emerging pharmacotherapies for Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2026
    24. GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling Science Progress · 2026
    25. Deciphering the molecular morphology of the human hair cycle: Wnt signalling during the telogen–anagen transformation British Journal of Dermatology · 2019 · 49 citations
    26. GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity Obesity Facts · 2025 · 3 citations
    27. Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review Wound Repair and Regeneration · 2025
    28. Escin Activates Canonical Wnt/β-Catenin Signaling Pathway by Facilitating the Proteasomal Degradation of Glycogen Synthase Kinase-3β in Cultured Human Dermal Papilla Cells Current Issues in Molecular Biology · 2023
    29. ISX9, a small molecule targeting Axin, activates Wnt/β-catenin signaling and promotes hair regrowth 2022
    30. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages Annals of the Rheumatic Diseases · 2014 · 36 citations